NDC 64764-800

Livtencity

Maribavir

Livtencity is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Maribavir.

• Product ID: 64764-800_9d1deed0-5538-4e6f-aaee-0e469820f4fd
• NDC: 64764-800
• Product Type: Human Prescription Drug
• Proprietary Name: Livtencity
• Generic Name: Maribavir
• Dosage Form: Tablet, Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-11-23
• Marketing Category: NDA /
• Application Number: NDA215596
• Labeler Name: Takeda Pharmaceuticals America, Inc.
• Substance Name: MARIBAVIR
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytomegalovirus pUL97 Kinase Inhibitor [EPC], Cytomegalovirus pUL97 Kinase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 64764-800-28

1 BOTTLE in 1 CARTON (64764-800-28) > 28 TABLET, COATED in 1 BOTTLE

• Marketing Start Date: 2021-11-23
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details